SlideShare ist ein Scribd-Unternehmen logo
1 von 3
1
Canine, 9yo FS Hound-X, presented 4/20/13 with a 2 week history of decreased appetite and one episode of
vomiting; represented several times in the weeks that follow (5/1/13, 5/13/13, 5/23/13, 5/28/13, 5/31/13,
6/7/13) for decreased appetite and/or vomiting
Historical hypercalcemia (serial PTH panels are equivocal for hyperparathyroidism)
Enlarged right cranial parathyroid gland seen on cervical US on 5/1/13, removed 5/15/13
Mild ventral edema noted throughout hospitalization.
5/1/13 5/13/13 5/16/13 5/23/13 5/28/13 5/31/13 6/7/13 6/8/13 6/9/13
HEMATOLOGY
RBC 8.01 6.36 7.20 6.82 7.15 5.33
HGB 16.0 12.8 14.3 13.4 14.3 11.8
HCT 48.9 38.3 43.8 40.4 41.7 33.0
PCV 48 38 43 41 43 33
P. PROTEIN 7.0 6.8 6.8 5.9 6.2 4.4
MCV 61.0 60.2 60.9 59.3 58.3 61.8
MCH 20.0 20.1 19.9 19.7 20.0 22.1
MCHC 32.7 33.4 32.7 33.2 34.3 35.7
PLT 203 174 213 188 115 37
MPV 8.1 7.8 8.3 8.9 10.4 14.5
SMEAR
WBC 9.10 14.53 22.94 28.48 24.57 8.11
SEGS 5.915 11.188 19.499 23.923 19.902 3.163
BANDS 0.459 1.424 1.720 3.568
LYMPH. 1.183 1.453 0.688 1.9936 0.246 0.487
MONO. 0.182 0.727 0.918 0.8544 1.474 0.568
EOS. 1.092 0.145 0.459 0.5696
BASO. 0.291 0.285
IMM. GRAN. 0.246 0.243
AB. LYMPH. 0.728 0.727 0.918 0.983 0.081
RE. LYMPH.
MAST
OTHER 2 (NRBC)
PUNCTATE RETICS
TOXIC SEGS SLIGHT MARKED
CHEMISTRY
GLUC 88 78 118 84 90 125 86 60 67
BUN 9 10 5 10 8 6 10 25 48
CREAT 1.1 0.9 0.6 0.9 0.9 0.8 0.8 1.9 3.8
PHOS 2.4 3.0 4.3 4.5 3.5 4.0 5.1 7.3 7.9
CA 13.4 13.2 10.0 10.6 9.3 9.1 9.4 8.6 7.5
MG 1.7 1.7 1.4 1.3 1.4 1.6 1.2 1.4 1.3
T. PROTEIN 6.2 6.1 5.0 6.0 5.7 5.1 5.2 4.1 3.2
ALB 3.1 3.0 2.5 2.6 2.7 2.4 2.2 1.8 1.2
GLOB 3.1 3.1 2.5 3.4 3.0 2.8 3.1 2.3 2.0
A:G 1.01 0.99 1.01 0.77 0.91 0.86 0.71 0.79 0.61
CHOL 216 239 169 255 257 215 239 176 116
T. BILI 0.1 0.2 0.2 0.2 0.2 0.4 0.4 1.7 5.9
ALP 258 439 39 677 597 597 1195 883 1553
ALT 126 178 75 144 109 103 200 227 1045
GGT 8 11 6 10 10 6 11 10 111
CK 119 169 205 227 238 243 256 1514 3266
NA 146 147 145 148 143 144 144 143 137
K 4.7 4.9 5.0 4.4 4.9 4.3 4.7 4.5 4.1
CL 112 112 116 115 112 113 112 114 114
HCO3 25 24 21 24 19 18 20 13 10
2
ANION GAP 13.8 16.2 12.7 13.3 16.5 16.6 17.4 20.7 16.8
NA:K 30.9 30.1 29.1 33.3 29.5 33.3 31.0 31.7 33.4
OSMOLALITY (CALC.) 288.7 290.1 287.9 290.8 283.0 284.3 285.6 287.2 283.2
AMY 1011 1229 1008 1358 1373 1151 1235 1723 1042
LIP 4440 6120 4800 7240 7860 8040 9780 14500 18380
OTHER TESTS
PLI >1000 850
PT 19.9
APTT >120
DIMER >5000
PLATELET 37
FIBRINOGEN 200
K9INR 3.00
Hypercalcemia is present initially, and resolves following parathyroidectomy, trending towards and eventually
resulting in hypocalcemia at the end of the patient’s hospitalization. Mild hypomagnesemia is present on all
chemistry panels performed. Hypercalcemia is likely due to hyperparathyroidism, and resolves accordingly
following parathyroidectomy. Hypomagnesia is likely due to hypercalcemia initially, as elevated calcium inhibits
renal reabsorption of Mg. Persistent hypomagnesemia prior to and following parathyroidectomy may be due to a
third space syndrome (likely the result of persistent hypoalbuminemia). Hypomagnesemia may be the cause of
hypocalcemia, as Mg is needed for the synthesis and release of PTH, and thus hypomagnesemia may eventually
result in a secondary hypocalcemia.
There is increased ALP activity, total bilirubin, and GGT, indicating cholestasis. An elevating trend of these values
indicates that cholestasis is worsening throughout the course of the patient’s hospitalizations. A trending increase
in ALT activity suggests hepatocellular injury. As with cholestasis, it appears that hepatocellular injury is
worsening throughout the patient’s hopsitalizations (particularly the last three days), due to a marked increase in
these values in the last days of hospitalization.
Amylase is normal or mildly elevated during hospitalization, while lipase has a worsening trend of severe elevation
(4440-18380; RR 12-147 IU/L). This may be due to a pancreatic lesion or primary renal failure. Given that BUN
and creatinine remain within normal limits (until the last two days of hospitalization), renal failure is an unlikely
cause. Additionally, elevated PLI is diagnostic for pancreatitis. However, urinalyses were not performed during
hospitalization, thus USG is not available and primary renal failure cannot be entirely ruled out.
Hypoalbuminemia is persistent beginning 5/16/13, with a worsening trend noted over the duration of
hospitalization. This may be due to loss as a result of protein-losing enteropathy and/or nephropathy (PLE/PLN),
and/or liver disease/failure. Concurrent increased ALT activity indicates some degree of hepatocellular injury,
lending support to liver disease/failure being the cause of hypoalbuminemia.
From 5/28/13-6/7/13, there is a moderate leukocytosis with a moderate neutrophilia and degenerate left shift, as
well as an monocytosis. A moderate lymphopenia is noted on 6/7/13. These changes are consistent with an
inflammatory response with a stress component.
On 6/9/13, leukocytes are within normal limits, and neutrophils are in the low normal range. However, a
degenerative left shift is still present, as bands outnumber neutrophils, and there are a marked amount of toxic
neutrophils present. Additionally, a mild normocytic, normochromic anemia and severe thrombocytopenia are
present. Together, these parameters indicate that a severe, overwhelming inflammatory response is present, and
gives the patient a guarded to poor prognosis.
A coagulation panel on 6/9/13 reveal a markedly elevation of PT, APTT, and D-dimers. This indicates that there are
decreased coagulation factors, and there are likely abnormalities in all arms of the coagulation cascade (intrinsic,
extrinsic, and/or common pathways). Markedly elevated D-dimers indicates that disseminated intravascular
3
coagulation (DIC) is present. Alone, this gives the patient a poor prognosis, and when combined with other
hematological and chemical abnormalities, gives the patient a grave prognosis.
Hypoglycemia, elevated BUN, creatine, and phosphorus, mild decrease in bicarbonate (indicating metabolic
acidosis), as well marked changes in all enzymes of the chemistry panel, combined with hematological parameters
and the coagulation panel indicate that the patient has severe disease in the pancreas, and is likely experiencing a
septic event. The most likely explanation is that, in addition to chronic pancreatitis, the patient is suffering from a
pancreatic adenocarcinoma (based on ultrasonographic appearance of the pancreas, as well as lymph nodes that
were biopsied and found to be devoid of lymphoid tissue but with many neoplastic cells), with widespread
metastatic multiorgan metastasis. This is may have served as the trigger for DIC and vascular injury.
Other tests that could have been performed during hospitalization include:
Urinalysis and UPC to rule out primary renal failure as a cause for elevated BUN and creatinine, as well as
elevated amylase and lipase
Blood gas to fully evaluate the patient’s acid/base status, with an arterial blood gas being preferred for
evaluation of lung pathology and potential PTE
Serial coagulation panels to assess coagulation status as a primary disease process during the course of
hospitalization(s), especially due to persistent elevations in ALT and ALP, as well as hypoalbuminemia (all
potential indicators of liver disease/failure)
Based on the patient’s rapid decline and grave prognosis, the owners elected humane euthanasia on 6/9/13.
Diagnosis at necropsy was a pancreatic adenocarcinoma with widespread multiorgan metastasis (including the
liver, lungs, spleen, and multiple lympho nodes), secondary pancreatic necrosis and fat necrosis with
saponification, and hemorrhage into the distal gastrointestinal tract. Petechiae were present in multiple organs,
supporting the clinical diagnosis of DIC. No renal lesions were noted.

Weitere ähnliche Inhalte

Was ist angesagt?

Metabolic liver disease presenting with cholestasis talk anshu srivastava
Metabolic liver disease presenting with  cholestasis talk anshu srivastavaMetabolic liver disease presenting with  cholestasis talk anshu srivastava
Metabolic liver disease presenting with cholestasis talk anshu srivastavaSanjeev Kumar
 
PFIC Patient Resource Information
PFIC Patient Resource InformationPFIC Patient Resource Information
PFIC Patient Resource InformationTylerBradley10
 
Takaysu Glomerulonephritis
Takaysu GlomerulonephritisTakaysu Glomerulonephritis
Takaysu GlomerulonephritisBeka Aberra
 
Progressiv familial intrahepatic cholestasis type 1 case presentation
Progressiv familial intrahepatic cholestasis type 1 case presentationProgressiv familial intrahepatic cholestasis type 1 case presentation
Progressiv familial intrahepatic cholestasis type 1 case presentationSanjeev Kumar
 
Post liver transplantation complications and immunosuppression
Post liver transplantation complications and immunosuppressionPost liver transplantation complications and immunosuppression
Post liver transplantation complications and immunosuppressionDr. Thakur Prashant Singh
 
Ascites related complications final
Ascites related complications finalAscites related complications final
Ascites related complications finalAmith Kumar
 
Dr ahmed shabaan case
Dr ahmed shabaan   caseDr ahmed shabaan   case
Dr ahmed shabaan caseFarragBahbah
 
Portal vein thrombosis: scenarios and principles of treatment
Portal vein thrombosis: scenarios and principles of treatmentPortal vein thrombosis: scenarios and principles of treatment
Portal vein thrombosis: scenarios and principles of treatmentDe Gottardi Andrea
 
Portal Hypertension
Portal HypertensionPortal Hypertension
Portal HypertensionSumit Roy
 
Caso clinico. apendicitis y lma
Caso clinico. apendicitis y lmaCaso clinico. apendicitis y lma
Caso clinico. apendicitis y lmaMaira Castaño
 
Ttp in immediate postpartum
Ttp in immediate postpartum Ttp in immediate postpartum
Ttp in immediate postpartum Maduka Sanjeewa
 
Metabolic Liver Disease definitions by Dr. Ashish Bavdekar
Metabolic Liver Disease definitions by Dr. Ashish BavdekarMetabolic Liver Disease definitions by Dr. Ashish Bavdekar
Metabolic Liver Disease definitions by Dr. Ashish BavdekarSanjeev Kumar
 
Non cirrhotic portal fibrosis
Non cirrhotic portal fibrosisNon cirrhotic portal fibrosis
Non cirrhotic portal fibrosisPratik Edwards
 
SBP and hepatic encephalopathy
SBP and hepatic encephalopathySBP and hepatic encephalopathy
SBP and hepatic encephalopathyKimberly Treier
 
Pediatric Liver Transplantation
Pediatric Liver TransplantationPediatric Liver Transplantation
Pediatric Liver TransplantationApollo Hospitals
 

Was ist angesagt? (20)

Metabolic liver disease presenting with cholestasis talk anshu srivastava
Metabolic liver disease presenting with  cholestasis talk anshu srivastavaMetabolic liver disease presenting with  cholestasis talk anshu srivastava
Metabolic liver disease presenting with cholestasis talk anshu srivastava
 
PFIC Patient Resource Information
PFIC Patient Resource InformationPFIC Patient Resource Information
PFIC Patient Resource Information
 
Takaysu Glomerulonephritis
Takaysu GlomerulonephritisTakaysu Glomerulonephritis
Takaysu Glomerulonephritis
 
Liver & hematological disorders
Liver & hematological disordersLiver & hematological disorders
Liver & hematological disorders
 
Progressiv familial intrahepatic cholestasis type 1 case presentation
Progressiv familial intrahepatic cholestasis type 1 case presentationProgressiv familial intrahepatic cholestasis type 1 case presentation
Progressiv familial intrahepatic cholestasis type 1 case presentation
 
Post liver transplantation complications and immunosuppression
Post liver transplantation complications and immunosuppressionPost liver transplantation complications and immunosuppression
Post liver transplantation complications and immunosuppression
 
Common liver problems for extern
Common liver problems for externCommon liver problems for extern
Common liver problems for extern
 
My research ppt
My research pptMy research ppt
My research ppt
 
Ascites related complications final
Ascites related complications finalAscites related complications final
Ascites related complications final
 
Dr ahmed shabaan case
Dr ahmed shabaan   caseDr ahmed shabaan   case
Dr ahmed shabaan case
 
Portal vein thrombosis: scenarios and principles of treatment
Portal vein thrombosis: scenarios and principles of treatmentPortal vein thrombosis: scenarios and principles of treatment
Portal vein thrombosis: scenarios and principles of treatment
 
Portal Hypertension
Portal HypertensionPortal Hypertension
Portal Hypertension
 
Caso clinico. apendicitis y lma
Caso clinico. apendicitis y lmaCaso clinico. apendicitis y lma
Caso clinico. apendicitis y lma
 
Ttp in immediate postpartum
Ttp in immediate postpartum Ttp in immediate postpartum
Ttp in immediate postpartum
 
Metabolic Liver Disease definitions by Dr. Ashish Bavdekar
Metabolic Liver Disease definitions by Dr. Ashish BavdekarMetabolic Liver Disease definitions by Dr. Ashish Bavdekar
Metabolic Liver Disease definitions by Dr. Ashish Bavdekar
 
Uremic Bleeding
Uremic BleedingUremic Bleeding
Uremic Bleeding
 
Uremic Bleed
Uremic BleedUremic Bleed
Uremic Bleed
 
Non cirrhotic portal fibrosis
Non cirrhotic portal fibrosisNon cirrhotic portal fibrosis
Non cirrhotic portal fibrosis
 
SBP and hepatic encephalopathy
SBP and hepatic encephalopathySBP and hepatic encephalopathy
SBP and hepatic encephalopathy
 
Pediatric Liver Transplantation
Pediatric Liver TransplantationPediatric Liver Transplantation
Pediatric Liver Transplantation
 

Andere mochten auch

Tutorial 2 abg summary
Tutorial 2 abg summaryTutorial 2 abg summary
Tutorial 2 abg summaryVivianOh96
 
Interpretation of the Arterial Blood Gas analysis
Interpretation of the Arterial Blood Gas analysisInterpretation of the Arterial Blood Gas analysis
Interpretation of the Arterial Blood Gas analysisVishal Golay
 
2015 Upload Campaigns Calendar - SlideShare
2015 Upload Campaigns Calendar - SlideShare2015 Upload Campaigns Calendar - SlideShare
2015 Upload Campaigns Calendar - SlideShareSlideShare
 
What to Upload to SlideShare
What to Upload to SlideShareWhat to Upload to SlideShare
What to Upload to SlideShareSlideShare
 
Getting Started With SlideShare
Getting Started With SlideShareGetting Started With SlideShare
Getting Started With SlideShareSlideShare
 

Andere mochten auch (8)

ABG tic tac toe
ABG tic tac toeABG tic tac toe
ABG tic tac toe
 
Tutorial 2 abg summary
Tutorial 2 abg summaryTutorial 2 abg summary
Tutorial 2 abg summary
 
Abg short seminar
Abg short seminarAbg short seminar
Abg short seminar
 
Interpretation of the Arterial Blood Gas analysis
Interpretation of the Arterial Blood Gas analysisInterpretation of the Arterial Blood Gas analysis
Interpretation of the Arterial Blood Gas analysis
 
Abg
AbgAbg
Abg
 
2015 Upload Campaigns Calendar - SlideShare
2015 Upload Campaigns Calendar - SlideShare2015 Upload Campaigns Calendar - SlideShare
2015 Upload Campaigns Calendar - SlideShare
 
What to Upload to SlideShare
What to Upload to SlideShareWhat to Upload to SlideShare
What to Upload to SlideShare
 
Getting Started With SlideShare
Getting Started With SlideShareGetting Started With SlideShare
Getting Started With SlideShare
 

Ähnlich wie Case Presentation: Pancreatic Clinical Chemistry Abnormalities

Iron deposit central large nodule in Alagille syndrome
Iron deposit central large nodule in Alagille syndromeIron deposit central large nodule in Alagille syndrome
Iron deposit central large nodule in Alagille syndromekomalicarol
 
LIVER DISEASE PPT.pptx
LIVER DISEASE PPT.pptxLIVER DISEASE PPT.pptx
LIVER DISEASE PPT.pptxfelixtamakloe1
 
managementofacuteliverfailureincriticalcare-160925104153.pdf
managementofacuteliverfailureincriticalcare-160925104153.pdfmanagementofacuteliverfailureincriticalcare-160925104153.pdf
managementofacuteliverfailureincriticalcare-160925104153.pdfHARYANVITRAVLLER
 
Management of acute liver failure in critical care
Management of acute liver failure in critical careManagement of acute liver failure in critical care
Management of acute liver failure in critical careChamika Huruggamuwa
 
Cirrhotic Ascites Review
Cirrhotic Ascites Review   Cirrhotic Ascites Review
Cirrhotic Ascites Review Brian Lee
 
Acute liver failure - what tomorrow might bring?
Acute liver failure - what tomorrow might bring? Acute liver failure - what tomorrow might bring?
Acute liver failure - what tomorrow might bring? SMACC Conference
 
An Unusual Case of Postpartum Thrombocytopenia
An Unusual Case of Postpartum ThrombocytopeniaAn Unusual Case of Postpartum Thrombocytopenia
An Unusual Case of Postpartum ThrombocytopeniaApollo Hospitals
 
Kenyatta university. liver funtion test
Kenyatta university. liver funtion testKenyatta university. liver funtion test
Kenyatta university. liver funtion testLando Elvis
 
MLT Clinical Case Study
MLT Clinical Case StudyMLT Clinical Case Study
MLT Clinical Case StudyAnneka Pierzga
 
Nonalcoholic fatty liver disease
Nonalcoholic fatty liver diseaseNonalcoholic fatty liver disease
Nonalcoholic fatty liver diseaseAshish Kumar
 
case microscopic polyangiitis
case microscopic polyangiitiscase microscopic polyangiitis
case microscopic polyangiitisPrachya Bung
 
11 Turman Management Of Acute Renal Failure In Picu
11 Turman   Management Of Acute Renal Failure In Picu11 Turman   Management Of Acute Renal Failure In Picu
11 Turman Management Of Acute Renal Failure In PicuDang Thanh Tuan
 

Ähnlich wie Case Presentation: Pancreatic Clinical Chemistry Abnormalities (20)

Iron deposit central large nodule in Alagille syndrome
Iron deposit central large nodule in Alagille syndromeIron deposit central large nodule in Alagille syndrome
Iron deposit central large nodule in Alagille syndrome
 
LIVER DISEASE PPT.pptx
LIVER DISEASE PPT.pptxLIVER DISEASE PPT.pptx
LIVER DISEASE PPT.pptx
 
managementofacuteliverfailureincriticalcare-160925104153.pdf
managementofacuteliverfailureincriticalcare-160925104153.pdfmanagementofacuteliverfailureincriticalcare-160925104153.pdf
managementofacuteliverfailureincriticalcare-160925104153.pdf
 
Management of acute liver failure in critical care
Management of acute liver failure in critical careManagement of acute liver failure in critical care
Management of acute liver failure in critical care
 
Surgery answers
Surgery answersSurgery answers
Surgery answers
 
Cirrhotic Ascites Review
Cirrhotic Ascites Review   Cirrhotic Ascites Review
Cirrhotic Ascites Review
 
NAFLD, NASH
NAFLD, NASHNAFLD, NASH
NAFLD, NASH
 
Acute liver failure - what tomorrow might bring?
Acute liver failure - what tomorrow might bring? Acute liver failure - what tomorrow might bring?
Acute liver failure - what tomorrow might bring?
 
A Case of Hepato-Pulmonary Syndrome
A Case of Hepato-Pulmonary SyndromeA Case of Hepato-Pulmonary Syndrome
A Case of Hepato-Pulmonary Syndrome
 
An Unusual Case of Postpartum Thrombocytopenia
An Unusual Case of Postpartum ThrombocytopeniaAn Unusual Case of Postpartum Thrombocytopenia
An Unusual Case of Postpartum Thrombocytopenia
 
201103coates.pdf
201103coates.pdf201103coates.pdf
201103coates.pdf
 
Kenyatta university. liver funtion test
Kenyatta university. liver funtion testKenyatta university. liver funtion test
Kenyatta university. liver funtion test
 
201103coates
201103coates201103coates
201103coates
 
MLT Clinical Case Study
MLT Clinical Case StudyMLT Clinical Case Study
MLT Clinical Case Study
 
Nonalcoholic fatty liver disease
Nonalcoholic fatty liver diseaseNonalcoholic fatty liver disease
Nonalcoholic fatty liver disease
 
case microscopic polyangiitis
case microscopic polyangiitiscase microscopic polyangiitis
case microscopic polyangiitis
 
11 Turman Management Of Acute Renal Failure In Picu
11 Turman   Management Of Acute Renal Failure In Picu11 Turman   Management Of Acute Renal Failure In Picu
11 Turman Management Of Acute Renal Failure In Picu
 
Acute liver failure
Acute liver failureAcute liver failure
Acute liver failure
 
Ecqs gastro
Ecqs gastroEcqs gastro
Ecqs gastro
 
Ecqs gastro
Ecqs gastroEcqs gastro
Ecqs gastro
 

Mehr von Omega Cantrell

Hyperlipemia in Equids
Hyperlipemia in EquidsHyperlipemia in Equids
Hyperlipemia in EquidsOmega Cantrell
 
Client Handout - Fleas
Client Handout - FleasClient Handout - Fleas
Client Handout - FleasOmega Cantrell
 
Ehrlichia canis in a dog with large granular lymphocytosis, thrombocytopenia,...
Ehrlichia canis in a dog with large granular lymphocytosis, thrombocytopenia,...Ehrlichia canis in a dog with large granular lymphocytosis, thrombocytopenia,...
Ehrlichia canis in a dog with large granular lymphocytosis, thrombocytopenia,...Omega Cantrell
 

Mehr von Omega Cantrell (13)

Hyperlipemia in Equids
Hyperlipemia in EquidsHyperlipemia in Equids
Hyperlipemia in Equids
 
Client Handout - Fleas
Client Handout - FleasClient Handout - Fleas
Client Handout - Fleas
 
Liver Enzymology
Liver EnzymologyLiver Enzymology
Liver Enzymology
 
Liver Enzymology
Liver EnzymologyLiver Enzymology
Liver Enzymology
 
Unknown bacteria
Unknown bacteriaUnknown bacteria
Unknown bacteria
 
N059 06 17-2011
N059 06 17-2011N059 06 17-2011
N059 06 17-2011
 
N059 06-17-2011
N059 06-17-2011N059 06-17-2011
N059 06-17-2011
 
Osteochondrosis
OsteochondrosisOsteochondrosis
Osteochondrosis
 
Ehrlichia canis in a dog with large granular lymphocytosis, thrombocytopenia,...
Ehrlichia canis in a dog with large granular lymphocytosis, thrombocytopenia,...Ehrlichia canis in a dog with large granular lymphocytosis, thrombocytopenia,...
Ehrlichia canis in a dog with large granular lymphocytosis, thrombocytopenia,...
 
VPI-VBMA Case Study
VPI-VBMA Case StudyVPI-VBMA Case Study
VPI-VBMA Case Study
 
AVS 406 Review Paper
AVS 406 Review PaperAVS 406 Review Paper
AVS 406 Review Paper
 
AVS 406 Presentation
AVS 406 PresentationAVS 406 Presentation
AVS 406 Presentation
 
AVS 406 Poster
AVS 406 PosterAVS 406 Poster
AVS 406 Poster
 

Kürzlich hochgeladen

Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Celine George
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactPECB
 
Measures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDMeasures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDThiyagu K
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...EduSkills OECD
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfagholdier
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdfQucHHunhnh
 
APM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAPM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAssociation for Project Management
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfAdmir Softic
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsTechSoup
 
BAG TECHNIQUE Bag technique-a tool making use of public health bag through wh...
BAG TECHNIQUE Bag technique-a tool making use of public health bag through wh...BAG TECHNIQUE Bag technique-a tool making use of public health bag through wh...
BAG TECHNIQUE Bag technique-a tool making use of public health bag through wh...Sapna Thakur
 
General AI for Medical Educators April 2024
General AI for Medical Educators April 2024General AI for Medical Educators April 2024
General AI for Medical Educators April 2024Janet Corral
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactdawncurless
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityGeoBlogs
 
9548086042 for call girls in Indira Nagar with room service
9548086042  for call girls in Indira Nagar  with room service9548086042  for call girls in Indira Nagar  with room service
9548086042 for call girls in Indira Nagar with room servicediscovermytutordmt
 
Web & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfWeb & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfJayanti Pande
 
A Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformA Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformChameera Dedduwage
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxiammrhaywood
 
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Sapana Sha
 

Kürzlich hochgeladen (20)

Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global Impact
 
Measures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDMeasures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SD
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdf
 
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptxINDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
 
APM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAPM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across Sectors
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdf
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The Basics
 
BAG TECHNIQUE Bag technique-a tool making use of public health bag through wh...
BAG TECHNIQUE Bag technique-a tool making use of public health bag through wh...BAG TECHNIQUE Bag technique-a tool making use of public health bag through wh...
BAG TECHNIQUE Bag technique-a tool making use of public health bag through wh...
 
General AI for Medical Educators April 2024
General AI for Medical Educators April 2024General AI for Medical Educators April 2024
General AI for Medical Educators April 2024
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impact
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activity
 
9548086042 for call girls in Indira Nagar with room service
9548086042  for call girls in Indira Nagar  with room service9548086042  for call girls in Indira Nagar  with room service
9548086042 for call girls in Indira Nagar with room service
 
Web & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfWeb & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdf
 
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
 
A Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformA Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy Reform
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
 
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
 

Case Presentation: Pancreatic Clinical Chemistry Abnormalities

  • 1. 1 Canine, 9yo FS Hound-X, presented 4/20/13 with a 2 week history of decreased appetite and one episode of vomiting; represented several times in the weeks that follow (5/1/13, 5/13/13, 5/23/13, 5/28/13, 5/31/13, 6/7/13) for decreased appetite and/or vomiting Historical hypercalcemia (serial PTH panels are equivocal for hyperparathyroidism) Enlarged right cranial parathyroid gland seen on cervical US on 5/1/13, removed 5/15/13 Mild ventral edema noted throughout hospitalization. 5/1/13 5/13/13 5/16/13 5/23/13 5/28/13 5/31/13 6/7/13 6/8/13 6/9/13 HEMATOLOGY RBC 8.01 6.36 7.20 6.82 7.15 5.33 HGB 16.0 12.8 14.3 13.4 14.3 11.8 HCT 48.9 38.3 43.8 40.4 41.7 33.0 PCV 48 38 43 41 43 33 P. PROTEIN 7.0 6.8 6.8 5.9 6.2 4.4 MCV 61.0 60.2 60.9 59.3 58.3 61.8 MCH 20.0 20.1 19.9 19.7 20.0 22.1 MCHC 32.7 33.4 32.7 33.2 34.3 35.7 PLT 203 174 213 188 115 37 MPV 8.1 7.8 8.3 8.9 10.4 14.5 SMEAR WBC 9.10 14.53 22.94 28.48 24.57 8.11 SEGS 5.915 11.188 19.499 23.923 19.902 3.163 BANDS 0.459 1.424 1.720 3.568 LYMPH. 1.183 1.453 0.688 1.9936 0.246 0.487 MONO. 0.182 0.727 0.918 0.8544 1.474 0.568 EOS. 1.092 0.145 0.459 0.5696 BASO. 0.291 0.285 IMM. GRAN. 0.246 0.243 AB. LYMPH. 0.728 0.727 0.918 0.983 0.081 RE. LYMPH. MAST OTHER 2 (NRBC) PUNCTATE RETICS TOXIC SEGS SLIGHT MARKED CHEMISTRY GLUC 88 78 118 84 90 125 86 60 67 BUN 9 10 5 10 8 6 10 25 48 CREAT 1.1 0.9 0.6 0.9 0.9 0.8 0.8 1.9 3.8 PHOS 2.4 3.0 4.3 4.5 3.5 4.0 5.1 7.3 7.9 CA 13.4 13.2 10.0 10.6 9.3 9.1 9.4 8.6 7.5 MG 1.7 1.7 1.4 1.3 1.4 1.6 1.2 1.4 1.3 T. PROTEIN 6.2 6.1 5.0 6.0 5.7 5.1 5.2 4.1 3.2 ALB 3.1 3.0 2.5 2.6 2.7 2.4 2.2 1.8 1.2 GLOB 3.1 3.1 2.5 3.4 3.0 2.8 3.1 2.3 2.0 A:G 1.01 0.99 1.01 0.77 0.91 0.86 0.71 0.79 0.61 CHOL 216 239 169 255 257 215 239 176 116 T. BILI 0.1 0.2 0.2 0.2 0.2 0.4 0.4 1.7 5.9 ALP 258 439 39 677 597 597 1195 883 1553 ALT 126 178 75 144 109 103 200 227 1045 GGT 8 11 6 10 10 6 11 10 111 CK 119 169 205 227 238 243 256 1514 3266 NA 146 147 145 148 143 144 144 143 137 K 4.7 4.9 5.0 4.4 4.9 4.3 4.7 4.5 4.1 CL 112 112 116 115 112 113 112 114 114 HCO3 25 24 21 24 19 18 20 13 10
  • 2. 2 ANION GAP 13.8 16.2 12.7 13.3 16.5 16.6 17.4 20.7 16.8 NA:K 30.9 30.1 29.1 33.3 29.5 33.3 31.0 31.7 33.4 OSMOLALITY (CALC.) 288.7 290.1 287.9 290.8 283.0 284.3 285.6 287.2 283.2 AMY 1011 1229 1008 1358 1373 1151 1235 1723 1042 LIP 4440 6120 4800 7240 7860 8040 9780 14500 18380 OTHER TESTS PLI >1000 850 PT 19.9 APTT >120 DIMER >5000 PLATELET 37 FIBRINOGEN 200 K9INR 3.00 Hypercalcemia is present initially, and resolves following parathyroidectomy, trending towards and eventually resulting in hypocalcemia at the end of the patient’s hospitalization. Mild hypomagnesemia is present on all chemistry panels performed. Hypercalcemia is likely due to hyperparathyroidism, and resolves accordingly following parathyroidectomy. Hypomagnesia is likely due to hypercalcemia initially, as elevated calcium inhibits renal reabsorption of Mg. Persistent hypomagnesemia prior to and following parathyroidectomy may be due to a third space syndrome (likely the result of persistent hypoalbuminemia). Hypomagnesemia may be the cause of hypocalcemia, as Mg is needed for the synthesis and release of PTH, and thus hypomagnesemia may eventually result in a secondary hypocalcemia. There is increased ALP activity, total bilirubin, and GGT, indicating cholestasis. An elevating trend of these values indicates that cholestasis is worsening throughout the course of the patient’s hospitalizations. A trending increase in ALT activity suggests hepatocellular injury. As with cholestasis, it appears that hepatocellular injury is worsening throughout the patient’s hopsitalizations (particularly the last three days), due to a marked increase in these values in the last days of hospitalization. Amylase is normal or mildly elevated during hospitalization, while lipase has a worsening trend of severe elevation (4440-18380; RR 12-147 IU/L). This may be due to a pancreatic lesion or primary renal failure. Given that BUN and creatinine remain within normal limits (until the last two days of hospitalization), renal failure is an unlikely cause. Additionally, elevated PLI is diagnostic for pancreatitis. However, urinalyses were not performed during hospitalization, thus USG is not available and primary renal failure cannot be entirely ruled out. Hypoalbuminemia is persistent beginning 5/16/13, with a worsening trend noted over the duration of hospitalization. This may be due to loss as a result of protein-losing enteropathy and/or nephropathy (PLE/PLN), and/or liver disease/failure. Concurrent increased ALT activity indicates some degree of hepatocellular injury, lending support to liver disease/failure being the cause of hypoalbuminemia. From 5/28/13-6/7/13, there is a moderate leukocytosis with a moderate neutrophilia and degenerate left shift, as well as an monocytosis. A moderate lymphopenia is noted on 6/7/13. These changes are consistent with an inflammatory response with a stress component. On 6/9/13, leukocytes are within normal limits, and neutrophils are in the low normal range. However, a degenerative left shift is still present, as bands outnumber neutrophils, and there are a marked amount of toxic neutrophils present. Additionally, a mild normocytic, normochromic anemia and severe thrombocytopenia are present. Together, these parameters indicate that a severe, overwhelming inflammatory response is present, and gives the patient a guarded to poor prognosis. A coagulation panel on 6/9/13 reveal a markedly elevation of PT, APTT, and D-dimers. This indicates that there are decreased coagulation factors, and there are likely abnormalities in all arms of the coagulation cascade (intrinsic, extrinsic, and/or common pathways). Markedly elevated D-dimers indicates that disseminated intravascular
  • 3. 3 coagulation (DIC) is present. Alone, this gives the patient a poor prognosis, and when combined with other hematological and chemical abnormalities, gives the patient a grave prognosis. Hypoglycemia, elevated BUN, creatine, and phosphorus, mild decrease in bicarbonate (indicating metabolic acidosis), as well marked changes in all enzymes of the chemistry panel, combined with hematological parameters and the coagulation panel indicate that the patient has severe disease in the pancreas, and is likely experiencing a septic event. The most likely explanation is that, in addition to chronic pancreatitis, the patient is suffering from a pancreatic adenocarcinoma (based on ultrasonographic appearance of the pancreas, as well as lymph nodes that were biopsied and found to be devoid of lymphoid tissue but with many neoplastic cells), with widespread metastatic multiorgan metastasis. This is may have served as the trigger for DIC and vascular injury. Other tests that could have been performed during hospitalization include: Urinalysis and UPC to rule out primary renal failure as a cause for elevated BUN and creatinine, as well as elevated amylase and lipase Blood gas to fully evaluate the patient’s acid/base status, with an arterial blood gas being preferred for evaluation of lung pathology and potential PTE Serial coagulation panels to assess coagulation status as a primary disease process during the course of hospitalization(s), especially due to persistent elevations in ALT and ALP, as well as hypoalbuminemia (all potential indicators of liver disease/failure) Based on the patient’s rapid decline and grave prognosis, the owners elected humane euthanasia on 6/9/13. Diagnosis at necropsy was a pancreatic adenocarcinoma with widespread multiorgan metastasis (including the liver, lungs, spleen, and multiple lympho nodes), secondary pancreatic necrosis and fat necrosis with saponification, and hemorrhage into the distal gastrointestinal tract. Petechiae were present in multiple organs, supporting the clinical diagnosis of DIC. No renal lesions were noted.